| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |